يعرض 1 - 18 نتائج من 18 نتيجة بحث عن '"Dokmetas, Hatice Sebile"', وقت الاستعلام: 0.41s تنقيح النتائج
  1. 1
    Academic Journal

    Relation: European journal of endocrinology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.1093/ejendo/lvae101; https://hdl.handle.net/11499/57905; 191; 312; 322; WOS:001307744600001

  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المساهمون: Erciyes Üniversitesi ,, 2604702

    Relation: PITUITARY; Hacioglu A., GÜNDOĞDU A., Nalbantoglu U., Karaca Z., URHAN M. E. , Sahin S., Dokmetas H. S. , KADIOĞLU P., Kelestimur F., "Gut microbiota in patients with newly diagnosed acromegaly: a pilot cross-sectional study", PITUITARY, cilt.24, ss.600-610, 2021; vv_1032021; av_c4ad3b23-205f-4c72-a580-30cb00f35c77; http://hdl.handle.net/20.500.12627/174126; https://doi.org/10.1007/s11102-021-01137-4; 24; 600; 610

  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal

    المساهمون: Ayvaz, Goksun Gazi Univ, Sch Med, TR-06500 Ankara, Turkey -- Keskin, Lezzan Malatya State Hosp, Malatya, Turkey -- Akin, Fulya Pamukkale Univ, Sch Med, Denizli, Turkey -- Dokmetas, Hatice Sebile Medipol Univ Hosp, Dept Endocrinol & Metab Dis, Istanbul, Turkey -- Dokmetas, Hatice Sebile Cumhuriyet Univ, Sch Med, Sivas, Turkey -- Tasan, Ertugrul Bezmialem Fdn Univ, Sch Med, Istanbul, Turkey -- Ar, Idilhan Baloglu -- Uren, Emel Novartis Pharma AG, Istanbul, Turkey, TASCI, ILKER -- 0000-0002-0936-2476, Ozisik, Lale -- 0000-0002-3494-8997, KOCA, Nizameddin -- 0000-0003-1457-4366

    مصطلحات موضوعية: DPP-4, HbA1c, Real-life, Type 2 diabetes Vildagliptin

    Relation: CURRENT MEDICAL RESEARCH AND OPINION; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://dx.doi.org/10.1185/03007995.2015.1019609; https://hdl.handle.net/20.500.12418/7900; 31; 632; 623

  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18

    المساهمون: Ondokuz Mayıs Üniversitesi, Zonguldak Bülent Ecevit Üniversitesi, [Ayvaz, Goksun] Gazi Univ, Sch Med, TR-06500 Ankara, Turkey -- [Keskin, Lezzan] Malatya State Hosp, Malatya, Turkey -- [Akin, Fulya] Pamukkale Univ, Sch Med, Denizli, Turkey -- [Dokmetas, Hatice Sebile] Medipol Univ Hosp, Dept Endocrinol & Metab Dis, Istanbul, Turkey -- [Dokmetas, Hatice Sebile] Cumhuriyet Univ, Sch Med, Sivas, Turkey -- [Tasan, Ertugrul] Bezmialem Fdn Univ, Sch Med, Istanbul, Turkey -- [Ar, Idilhan Baloglu -- Uren, Emel] Novartis Pharma AG, Istanbul, Turkey, TASCI, ILKER -- 0000-0002-0936-2476, Ozisik, Lale -- 0000-0002-3494-8997, KOCA, Nizameddin -- 0000-0003-1457-4366, Maltepe Üniversitesi

    مصطلحات موضوعية: metabolic disorder, Male, drug safety, Pyrrolidines, genetic structures, endocrine system diseases, Turkey, kidney disease, peripheral edema, Peripheral edema, diarrhea, gastrointestinal symptom, eye disease, Adamantane, Type 2 diabetes, heart disease, Pharmacology, mental disease, Turkey (republic), Body Mass Index, Cohort Studies, analogs and derivatives, DPP-4, middle aged, Vildagliptin, Prospective Studies, Prospective cohort study, hemoglobin A1c, drug monitoring, education.field_of_study, nitrile, non insulin dependent diabetes mellitus, adult, Real-life, add on therapy, vascular disease, clinical trial, General Medicine, Middle Aged, nausea, cohort analysis, Metformin, ComputingMilieux_MANAGEMENTOFCOMPUTINGANDINFORMATIONSYSTEMS, female, Treatment Outcome, Tolerability, chemically induced, Female, Drug Therapy, Combination, liver enzyme, InformationSystems_MISCELLANEOUS, medicine.symptom, Drug Monitoring, medicine.drug, prospective study, medicine.medical_specialty, HbA1c, Population, drug combination, Article, Type 2 Diabetes Vildagliptin, skin manifestation, Type 2 diabetes Vildagliptin, Internal medicine, pyrrolidine derivative, Nitriles, medicine, Humans, Hypoglycemic Agents, human, education, glycosylated hemoglobin, Glycated Hemoglobin, Hemoglobin A, Glycosylated, Dipeptidyl-Peptidase IV Inhibitors, business.industry, ComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKS, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, antidiabetic agent, constipation, medicine.disease, major clinical study, body mass, Hypoglycemia, drug efficacy, ComputingMethodologies_PATTERNRECOGNITION, multicenter study, Diabetes Mellitus, Type 2, weight reduction, business, dipeptidyl peptidase IV inhibitor, drug tolerability

    وصف الملف: application/pdf